PLG and cancer: Most notably, a significant proportion of the ENO1 protein redistributes to the surface of cancer cells, wherein it evolves proteolytic functions through activating the uPAR/plasminogen/MMP axis (38), thereby contributing to tumor progression in particular the process of metastasis.